Peeters KCMJ - Search Results

1

Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.

Hazen SJA, Sluckin TC, Intven MPW, Beets GL, Beets-Tan RGH, Borstlap WAA, Buffart TE, Buijsen J, Burger JWA, van Dieren S, Furnée EJB, Geijsen ED, Hompes R, Horsthuis K, Leijtens JWA, Maas M, Melenhorst J, Nederend J, Peeters KCMJ, Rozema T, Tuynman JB, Verhoef C, de Vries M, van Westreenen HL, de Wilt JHW, Zimmerman DDE, Marijnen CAM, Tanis PJ, Kusters M; Dutch Snapshot Research Group. Hazen SJA, et al. Among authors: peeters kcmj. JAMA Oncol. 2024 Feb 1;10(2):202-211. doi: 10.1001/jamaoncol.2023.5444. JAMA Oncol. 2024. PMID: 38127337

2

The gastric cancer treatment controversy.

van de Velde CJ, Peeters KC. van de Velde CJ, et al. J Clin Oncol. 2003 Jun 15;21(12):2234-6. doi: 10.1200/JCO.2003.91.138. J Clin Oncol. 2003. PMID: 12805321 No abstract available.

3

Managing rectal cancer: the Dutch experience.

Peeters KC, Kapiteijn E, van de Velde CJ; Dutch ColoRectal Cancer Group. Peeters KC, et al. Colorectal Dis. 2003 Sep;5(5):423-6. doi: 10.1046/j.1463-1318.2003.00513.x. Colorectal Dis. 2003. PMID: 12925073

4

Surgical quality assurance in breast, gastric and rectal cancer.

Peeters KC, van de Velde CJ. Peeters KC, et al. J Surg Oncol. 2003 Nov;84(3):107-12. doi: 10.1002/jso.10312. J Surg Oncol. 2003. PMID: 14598352 Review. No abstract available.

5

Improving treatment outcome for gastric cancer: the role of surgery and adjuvant therapy.

Peeters KC, van de Velde CJ. Peeters KC, et al. J Clin Oncol. 2003 Dec 1;21(23 Suppl):272s-273s. doi: 10.1200/JCO.2003.09.136. J Clin Oncol. 2003. PMID: 14645408 No abstract available.

6

Minimal residual disease assessment in sentinel nodes of breast and gastrointestinal cancer: a plea for standardization.

Doekhie FS, Peeters KC, Tollenaar RA, van de Velde CJ. Doekhie FS, et al. Ann Surg Oncol. 2004 Mar;11(3 Suppl):236S-41S. doi: 10.1007/BF02523636. Ann Surg Oncol. 2004. PMID: 15023759 Review.

7

Quality assurance of surgery in gastric and rectal cancer.

Peeters KC, van de Velde CJ. Peeters KC, et al. Crit Rev Oncol Hematol. 2004 Aug;51(2):105-19. doi: 10.1016/j.critrevonc.2004.04.003. Crit Rev Oncol Hematol. 2004. PMID: 15276175 Review.

8

Risk factors for anastomotic failure after total mesorectal excision of rectal cancer.

Peeters KC, Tollenaar RA, Marijnen CA, Klein Kranenbarg E, Steup WH, Wiggers T, Rutten HJ, van de Velde CJ; Dutch Colorectal Cancer Group. Peeters KC, et al. Br J Surg. 2005 Feb;92(2):211-6. doi: 10.1002/bjs.4806. Br J Surg. 2005. PMID: 15584062 Clinical Trial.

9

Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma.

Peeters KC, Kattan MW, Hartgrink HH, Kranenbarg EK, Karpeh MS, Brennan MF, van de Velde CJ. Peeters KC, et al. Cancer. 2005 Feb 15;103(4):702-7. doi: 10.1002/cncr.20783. Cancer. 2005. PMID: 15641033 Free article.

10

Surgical quality assurance in rectal cancer treatment: the key to improved outcome.

Peeters KC, van de Velde CJ. Peeters KC, et al. Eur J Surg Oncol. 2005 Aug;31(6):630-5. doi: 10.1016/j.ejso.2005.02.020. Eur J Surg Oncol. 2005. PMID: 15878260 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page